Growth hormone improves growth retardation induced by rapamycin without blocking its antiproliferative and antiangiogenic effects on rat growth plate

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Álvarez García, Óscar ^a,b   García López, Enrique ^c   Loredo, Vanessa ^c   Gil Peña, Helena ^c   Mejía Gaviria, Natalia ^a   Rodríguez Suárez, Julián ^a,c   Ordóñez, Flor Á ^c   Santos, Fernando ^a,b,c  

^a UNIVERSITY OF OVIEDO   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3BETA; HUMAN GROWTH HORMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RAPAMYCIN; SOMATOMEDIN C; ANTINEOPLASTIC ANTIBIOTIC; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; GROWTH HORMONE; MITOGEN ACTIVATED PROTEIN KINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; AUTOPHAGY; BODY HEIGHT; CARTILAGE CELL; CELL MATURATION; CELL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; ENZYME INACTIVATION; FEMALE; GROWTH PLATE; GROWTH RATE; GROWTH RETARDATION; HORMONAL THERAPY; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; RAT; THERAPY EFFECT; ANIMAL; CELL DIFFERENTIATION; CHILD; CHONDROGENESIS; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALIA; RATTUS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AUTOPHAGY; BETA CATENIN; CELL DIFFERENTIATION; CHILD; CHONDROCYTES; CHONDROGENESIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3; GROWTH HORMONE; GROWTH PLATE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SIROLIMUS;

EID: 84859508642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034788     Document Type: Article

References (27)

1. Wullschleger S, Loewith R, Hall MN, (2006) TOR signaling in growth and metabolism. Cell 124: 471-484.
2. Geissler EK, Schlitt HJ, (2010) The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation. Kidney Int 78: 1075-1079.
3. Koehl GE, Andrassy J, Guba M, Richter S, Kroemer A, et al. (2004) Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation 77: 1319-1326.
4. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, et al. (2007) Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356: 2271-2281.
5. Cravedi P, Ruggenenti P, Remuzzi G, (2009) Sirolimus to replace calcineurin inhibitors? Too early yet. Lancet 373: 1235-1236.
6. Ibáñez JP, Monteverde ML, Goldberg J, Diaz MA, Turconi A, (2005) Sirolimus in pediatric renal transplantation. Transplant Proc 37: 682-684.
7. Fine RN, (2007) Management of growth retardation in pediatric recipients of renal allografts. Nat Clin Pract Nephrol 3: 318-324.
8. Alvarez-Garcia O, Carbajo-Pérez E, Garcia E, Gil H, Molinos I, et al. (2007) Rapamycin retards growth and causes marked alterations in the growth plate of young rats. Pediatr Nephrol 22: 954-961.
9. Alvarez-García O, García-López E, Loredo V, Gil-Peña H, Rodríguez-Suárez J, et al. (2010) Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate. Kidney Int 78: 561-518.
10. González D, García CD, Azócar M, Waller S, Alonso A, et al. (2011) Growth of kidney-transplanted pediatric patients treated with sirolimus. Pediatr Nephrol 26: 961-966.
11. Sanchez CP, He YZ, (2009) Bone growth during rapamycin therapy in young rats. BMC Pediatr 9: 3.
12. Phornphutkul C, Lee M, Voigt C, Wu KY, Ehrlich MG, et al. (2009) The effect of rapamycin on bone growth in rabbits. J Orthop Res 27: 1157-1161.
13. Rangel GA, Ariceta G, (2009) Growth failure associated with sirolimus: case report. Pediatr Nephrol 24: 2047-2050.
14. van der Eerden BC, Karperien M, Wit JM, (2003) Systemic and local regulation of the growth plate. Endocr Rev 24: 782-801.
15. Molinos I, Santos F, Carbajo-Perez E, Garcia E, Rodriguez J, et al. (2006) Catch-up growth follows an abnormal pattern in experimental renal insufficiency and growth hormone treatment normalizes it. Kidney Int 70: 1955-1961.
16. Wilsman NJ, Farnum CE, Leiferman EM, Fry M, Barreto C, (1996) Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics. J Orthop Res 14: 927-936.
17. Cobo A, López JM, Carbajo E, Santos F, Alvarez J, et al. (1999) Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats. J Am Soc Nephrol 10: 971-979.
18. Bohensky J, Leshinsky S, Srinivas V, Shapiro IM, (2010) Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression. Pediatr Nephrol 25: 633-642.
19. Srinivas V, Bohensky J, Shapiro IM, (2009) Autophagy: a new phase in the maturation of growth plate chondrocytes is regulated by HIF, mTOR and AMP kinase. Cells Tissues Organs 189: 88-92.
20. Mizushima N, Yoshimori T, Levine B, (2010) Methods in mammalian autophagy research. Cell 140: 313-326.
21. Kawasaki Y, Kugimiya F, Chikuda H, Kamekura S, Ikeda T, et al. (2008) Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes. J Clin Invest 118: 2506-2515.
22. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A, (2001) The somatomedin hypothesis: 2001. Endocr Rev 22: 53-74.
23. Cohen P, Frame S, (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776.
24. Guo X, Mak KK, Taketo MM, Yang Y, (2009) The Wnt/beta-catenin pathway interacts differentially with PTHrP signaling to control chondrocyte hypertrophy and final maturation. PLoS One 4: e6067.
25. Gillespie JR, Ulici V, Dupuis H, Higgs A, Dimattia A, et al. (2011) Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression. Endocrinology 152: 1755-1766.
26. Murakami S, Balmes G, McKinney S, Zhang Z, Givol D, et al. (2004) Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev 18: 290-305.
27. Dharnidharka VR, Talley LI, Martz KL, Stablein DM, Fine RN, (2008) Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease-a report of the NAPRTCS. Pediatr Transplant 12: 689-695.